Session 8: Blood Borne Viruses - Viral Hepatitis Flashcards

1
Q

Definition of hepatitis.

A

Inflammation of liver.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Where does hepatitis viruses replicate?

A

In the hepatocytes (hepatotropic) Destroys hepatocytes as well.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Label the diagram.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Explain the production and excretion of bilirubin.

A

RBCs -> Haemoglobin -> Biliverdin -> Bilirubin (into blood stream) -> Bilirubin albumin -> (into liver) -> Bilirubin conjugated into conjugated bilirubin then either excreted into urine or sent as bile into small intestine where it becomes urobilinogen. Urobilinogen can then either enter enterohepatic circulation and go back to liver, or it can become urobilin stercobilin and be excreted in feces.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Give types of jaundice. Give cause as well.

Where do they take place?

A

Prehepatic takes place outside of the liver in reticuloendothelial system due to haemolysis.

Cholestatic (two subgroups):

Intrahepatic and Extrahepatic

Intrahepatic is in the liver

Extrahepatic is somewhere in the bile duct.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Causes of intrahepatic jaundice.

A

Viral hepatitis
Drugs
Alcoholic hepatitis
Cirrhosis
Autoimmune cholangitis
Pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Causes of extrahepatic jaundice.

A

Any obstruction of bile:

Common duct stones
Carcinoma
Biliary stricture
Sclerosin cholangitis
Pancreatitic pseudocyst

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Give liver function tests.

A

Bilirubin

Liver transaminases (ALT, AST)

Alkaline phosphatase (ALP)

Albumin

Tests of coagulation like clotting factors, INR and PT.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

If a blood test comes back with elevated Bilirubin and ALT but normal ALP and normal Hb. What does that suggest?

A

Reduced liver function.

No damage to biliary tract (ALP).

No haemolysis (Hb)

Intra-hepatic jaundice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Transmission of Hep B. Who’s at risk?

A

Vertical transmission most common (75% of cases)

Sexual contact

People who inject drugs

Close household contacts

Significant blood exposure

HCW via needlestick injuries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Symptoms of Acute Hep B.

A

Can vary and also be asymptomatic however:

Jaundice
Fatigue
Abdo pain
Anorexia/Nausea/Vomiting
Arthralgia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Prevalence of Hep B becoming chronic.

A

<10% of infected as adults

90% if infected in infancy in Asia/China

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Serology of Hep B.

A

HBsAg (Surface antigen) will rise withing 6/52 causing rise in ALT and DNA.

This is followed by e-antigen which is highly infectious.

Followed by core antibody (IgM) which is the first antibody to appear.

Followed by e-antibody which heralds disapperance of e-antigen and lowers infectivity.

Surface antibody appears which is the last antibody to appear and clears virus and starts recovery.

Core antibody (IgG) persists for life.

HBV DNA PCR is used to test.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Definition of chronic Hep B.

A

Persistence of HBsAg after 6 months (surface antigen).

25% chronic infections leads to cirrhosis and 5% will develop hepatocellular carcinoma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Treatment of hep B

A

No cure so life-long anti-virals to suppress viral replication may be needed. It is however not required for everyone.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How do you prevent Hep B?

A

By vaccination.

Genetically engineered surface antigen.

3 doses + boosters if required

Effective in most people

Produces surface antibody response.

>10 adequate

>100 long term protection

17
Q

Complete the table

A
18
Q

Transmission of Hepatitis C. Who is at risk?

A

People who inject drugs i.e. IV drug users.

IV heroin, crack and meth

Also crack or heroin smokers.

Sexual contact is below 1% but high if HIV co-infected

Perinatal is below 5%

Blood transfusions prior to 1991

Needlestick injuries

19
Q

Once contracted Hep C how many will be chronically infected?

A

80%

20
Q

Complications of chronic Hepatitis C infection.

A

Decompensated liver disease

Hepatocellular carcinoma

Needing liver transplant

All this from chronic liver disease/cirrhosis

21
Q

Symptoms of hepatitis C (acute or chronic)

A

80% have no symptoms

20% get fatigue, anorexia, nausea and abdo pain in right upper quadrant.

22
Q

Blood tests for hepatitis C.

A

Seroloy - anti-Hep C antibody only however this will not tell you if you have the infection or if you have been cured.

The anti-Hep C antibodies are no protective like in Hep-B meaning you can get re-infected.

Viral PCR is needed to confirm diagnosis. If this is positive you can confirm an on-going or chronic Hep C infection.

23
Q

Treatment of Hep C.

A

Directly acting antiviral drug combo

8-12 weeks with a over a 90% chance of cure however it is very expensive (20000 pounds to 60000 pounds per course) and you can still get re-infected.

There are no vaccines.

24
Q

A 25 yo IVDU is admitted and known to be HIV positive.

Med student is asked to take blood test and after the blood test pricks her thumb with the same needle.

What should she do?

(Think post-exposure prophylaxis (PEP))

A

Test for HIV, Hep C and Hep B.

Immediate measures such as first aid where you bleed and wash the wound.

Collect blood from patient to see their levels and disease.

Inform occupational health

Chech the med students Hep B vaccination status.

Assess risk and need for immediate HIV PEP

Give ARVs for 28 days (3x) and start it as soon as possible max up to 72 hours after needlestick.

HIV test at baseline 1 month and 3 months after initial test.